Cardiac arrhythmia and sudden death can occur; so, cardiac monitoring should be performed, calcium gluconate may need to be administrated, and potassium‐lowering strategies such as glucose/insulin infusion, beta‐agonist inhalation, and oral potassium‐binding agents may also be used. This evidence concerns the gene INS and cardiac arrhythmia.